Childhood cancers trials in Russia

In Russia 23 Also abroad 2459

23 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Dabrafenib and/or Trametinib Rollover Study
Where
Moscow
Age
18 years to 100 years
People
100 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00
Phase 2Taking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Moscow, Saint Petersburg, Ufa
Age
12 years and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
Phase 4Taking people
Asciminib Roll-over Study
Where
Moscow, Saint Petersburg
Age
7 years to 100 years
People
347 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00
Phase 3Taking people
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
Where
Moscow, Moskva
People
200 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT05862285 · EU 2023-504263-16-00
Phase 2Taking people
Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker Decline
Where
Moscow
Age
16 years and over
People
60
Run by
Blokhin's Russian Cancer Research Center
See details and how to joinNCT07847190
No phaseTaking people
Prevention of Bile Leakage After Liver Resection in Children
Where
Moscow
Age
0 years to 18 years
People
12
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT07867522
Phase 3Taking people
CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)
Where
Moscow
People
430
Run by
Russian Society of Colorectal Surgeons
See details and how to joinNCT06119867
Phase 3Taking people
Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy
Where
Moscow
People
100
Run by
Blokhin's Russian Cancer Research Center
See details and how to joinNCT07633236
Phase 3Taking people
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Where
Moscow, Yekaterinburg
Age
Up to 18 years
People
683 worldwide
Run by
University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00
Phase 3Taking people
Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma
Where
Moscow
Age
18 months to 18 years
People
5
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT07375563
Phase 2/3Taking people
Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
Where
Moscow
Age
1 year to 25 years
People
64
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT07366801
Phase 2Taking people
Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation
Where
Moscow
Age
1 month to 25 years
People
15
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT07256210
Phase 3Taking people
The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia
Where
Moscow
Age
1 day to 18 years
People
100
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT07232134
No phaseNot yet taking people in Russia
Study of Colorectal Anastomosis Failures With First Sigmoid or Left Colonic Artery Preservation With D3 Lymphadenectomy
Where
Saint Petersburg
People
778
Run by
the BELOOSTROV Clinic of High Technologies
See details and how to joinNCT06938490
Phase 2Enrolling by invitation
Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment
Where
Moscow, Saint Petersburg
Age
2 years to 18 years
People
20
Run by
St. Petersburg State Pavlov Medical University
See details and how to joinNCT06931613
Phase 2Taking people
Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
Where
Novosibirsk
People
130 worldwide
Run by
Population Health Research Institute
See details and how to joinNCT04680442
Phase 1/2Enrolling by invitation
Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma
Where
Moscow, Saint Petersburg
Age
Up to 18 years
People
22
Run by
St. Petersburg State Pavlov Medical University
See details and how to joinNCT06871007
Phase 2/3Taking people
Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis
Where
Moscow
Age
1 day to 21 years
People
50
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT06756152
Phase 3Taking people
Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)
Where
Moscow
Age
1 day to 365 days
People
80
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT05029531
No phaseTaking people
Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification
Where
Moscow
Age
1 day to 18 years
People
200
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT06296732
No phaseTaking people
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
Where
Saint Petersburg
Age
1 year and over
People
1,000
Run by
N.N. Petrov National Medical Research Center of Oncology
See details and how to joinNCT05539677
Phase 3Taking people
Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma
Where
Moscow
Age
18 months to 18 years
People
15
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT06071897
Phase 4Taking people
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
Where
Moscow
Age
1 day to 18 years
People
300
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT05518383